CDK4 and breast cancer: Furthermore, BC cell lines that expressed an ALTernatively-spliced form of Brk (ALT), lacking the SH1 kinase domain, failed to phosphorylate p27 on its tyrosine residues, resulting in increased CDK4 and CDK2 inhibition following Palbociclib administration (88).